Variable | HIV negative | HIV positive | p-value | ||
---|---|---|---|---|---|
N | % | N | % | ||
 | 293 | 30.3 | 674 | 69.7 |  |
Age categories | Â | Â | Â | Â | Â |
 < 30 | 2 | 0.7 | 11 | 1.6 |  < 0.001* |
 ≥ 30–40 | 23 | 7.9 | 165 | 24.5 |  |
 ≥ 40–50 | 44 | 15.1 | 324 | 48.1 |  |
 ≥ 50–60 | 60 | 20.5 | 119 | 17.7 |  |
 ≥ 60–70 | 98 | 33.6 | 47 | 7.0 |  |
 ≥ 70 | 65 | 22.3 | 8 | 1.2 |  |
Residence | Â | Â | Â | Â | Â |
 Rural | 250 | 85.3 | 511 | 76.0 |  < 0.001* |
 Urban | 43 | 14.7 | 161 | 24.0 |  |
Marital status | Â | Â | Â | Â | Â |
 Never married/single | 140 | 47.8 | 498 | 74.0 |  < 0.001* |
 Married | 91 | 31.1 | 132 | 19.6 |  |
 Divorced | 3 | 1.0 | 9 | 1.3 |  |
 Widowed | 59 | 20.1 | 34 | 5.1 |  |
Previous cervical cancer screening | Â | Â | Â | Â | Â |
 Never screened | 143 | 51.6 | 248 | 38.2 |  < 0.001* |
 Screened | 134 | 48.4 | 401 | 61.8 |  |
Visit with a traditional healer | Â | Â | Â | Â | Â |
 No | 250 | 87.7 | 599 | 90.9 | 0.140 |
 Yes | 35 | 12.3 | 60 | 9.1 |  |
FIGO Stage | Â | Â | Â | Â | Â |
 I | 48 | 17.0 | 115 | 17.8 | 0.83 |
 II | 106 | 37.6 | 225 | 34.9 |  |
 III | 100 | 35.5 | 245 | 38.0 |  |
 IV | 28 | 9.9 | 60 | 9.3 |  |
Pathology | Â | Â | Â | Â | Â |
 SCC | 239 | 83.9 | 583 | 88.9 | 0.022* |
 Adenocarcinoma | 31 | 10.9 | 33 | 5.0 |  |
 Invasive ductal | 1 | 0.4 | 3 | 0.5 |  |
 Other | 9 | 3.2 | 30 | 4.6 |  |
 Vascular invasion | 0 | 0 | 1 | 0.2 |  |
 Unknown | 5 | 1.8 | 6 | 0.9 |  |
Abnormal vaginal bleeding | Â | Â | Â | Â | Â |
 Not reported | 68 | 23.2 | 192 | 28.5 | 0.089 |
 Reported | 225 | 76.8 | 482 | 71.5 |  |
CD4 | Â | Â | Â | Â | Â |
 < 250 cells/mm3 | – | – | 117 | 21.4 | – |
 ≥ 250 cells/mm3 | – | – | 429 | 78.6 |  |
ART | Â | Â | Â | Â | Â |
 No | – | – | 25 | 3.8 | – |
 Yes | – | – | 640 | 96.2 |  |